The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cessation and Nicotine De-Addiction Market Research Report 2025
Synopsis
The global Cessation and Nicotine De-Addiction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Cation and nicotine de-addiction programs and products are driven by several factors aimed at addressing the addictive nature of nicotine, reducing tobacco use, and improving public health. Some of the driving factors include:
1. Health concerns: The primary factor driving cessation and nicotine de-addiction efforts is the recognition of the harmful health effects of nicotine and tobacco use. Evidence shows that tobacco use is a leading cause of preventable diseases, including various types of cancer, heart disease, and respiratory problems. Concerns about these health risks drive individuals and organizations to seek ways to quit nicotine addiction and tobacco use.
2. Government and public health initiatives: Governments and public health organizations play a vital role in driving cessation and de-addiction efforts. They implement comprehensive tobacco control measures, including policies, regulations, and public awareness campaigns, to promote quitting and reduce tobacco consumption. Public health initiatives often provide resources, support, and education to individuals seeking to quit using nicotine products.
3. Nicotine replacement therapy (NRT): NRT products, such as nicotine patches, gums, lozenges, inhalers, and nasal sprays, are commonly used in cessation and de-addiction programs. These products provide controlled doses of nicotine without the harmful toxins found in tobacco smoke, helping individuals gradually reduce their dependence on nicotine while managing withdrawal symptoms. The availability and effectiveness of NRT products contribute to driving cessation efforts.
4. Behavioral support and counseling: Along with pharmacotherapy, behavioral support and counseling play a crucial role in driving successful cessation and de-addiction. Counseling programs provide individuals with guidance, motivation, and coping strategies to manage cravings, triggers, and psychological dependencies associated with nicotine addiction. Behavioral interventions and support groups help individuals stay motivated and maintain long-term abstinence.
5. Increasing awareness and education: Awareness campaigns, educational programs, and public health initiatives aimed at highlighting the risks of nicotine addiction contribute to driving cessation efforts. By increasing awareness about the addictive nature of nicotine, the health consequences of tobacco use, and the benefits of quitting, individuals are motivated to seek nicotine de-addiction support.
6. Social and cultural factors: Changes in social norms and cultural attitudes toward smoking and tobacco use have also driven cessation efforts. As society becomes more conscious of the health risks and the negative societal impact of smoking, individuals are more likely to seek methods and support to quit nicotine addiction and give up tobacco use.
7. Accessibility of cessation programs and products: The availability and accessibility of cessation programs and nicotine replacement therapies influence individual decisions to seek help and attempt quitting. Increased availability, affordability, and ease of access to cessation resources, including counseling services, medications, and online support programs, contribute to the driving factors for nicotine de-addiction.
8. Peer influence and support: Peer support and encouragement from friends, family, and social networks play a significant role in driving cessation and de-addiction efforts. The support of others who have successfully quit or are going through the same process can provide motivation, guidance, and a sense of community during the quitting journey.
Overall, the driving factors for cessation and nicotine de-addiction include health concerns, government initiatives, NRT products, behavioral support, increasing awareness, changing social norms, accessibility of cessation programs and products, and peer influence. By addressing these factors and providing effective support, cessation and de-addiction efforts aim to reduce tobacco use, improve public health, and promote a tobacco-free society.
This report aims to provide a comprehensive presentation of the global market for Cessation and Nicotine De-Addiction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cessation and Nicotine De-Addiction.
Report Scope
The Cessation and Nicotine De-Addiction market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cessation and Nicotine De-Addiction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cessation and Nicotine De-Addiction companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kimree Technology Co.
GSK
Johnson & Johnson
Dr. Reddy’s Laboratories
Novartis AG
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Pfizer
Smoke Away
V2 Electronic Cigarettes
VaporFi
Mig Vapor
Halo Cigs
Segment by Type
Drug therapy
Nicotine Replacement Therapy (NRT)
Electronic cigarettes (E-cigarettes)
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cessation and Nicotine De-Addiction companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cessation and Nicotine De-Addiction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Cation and nicotine de-addiction programs and products are driven by several factors aimed at addressing the addictive nature of nicotine, reducing tobacco use, and improving public health. Some of the driving factors include:
1. Health concerns: The primary factor driving cessation and nicotine de-addiction efforts is the recognition of the harmful health effects of nicotine and tobacco use. Evidence shows that tobacco use is a leading cause of preventable diseases, including various types of cancer, heart disease, and respiratory problems. Concerns about these health risks drive individuals and organizations to seek ways to quit nicotine addiction and tobacco use.
2. Government and public health initiatives: Governments and public health organizations play a vital role in driving cessation and de-addiction efforts. They implement comprehensive tobacco control measures, including policies, regulations, and public awareness campaigns, to promote quitting and reduce tobacco consumption. Public health initiatives often provide resources, support, and education to individuals seeking to quit using nicotine products.
3. Nicotine replacement therapy (NRT): NRT products, such as nicotine patches, gums, lozenges, inhalers, and nasal sprays, are commonly used in cessation and de-addiction programs. These products provide controlled doses of nicotine without the harmful toxins found in tobacco smoke, helping individuals gradually reduce their dependence on nicotine while managing withdrawal symptoms. The availability and effectiveness of NRT products contribute to driving cessation efforts.
4. Behavioral support and counseling: Along with pharmacotherapy, behavioral support and counseling play a crucial role in driving successful cessation and de-addiction. Counseling programs provide individuals with guidance, motivation, and coping strategies to manage cravings, triggers, and psychological dependencies associated with nicotine addiction. Behavioral interventions and support groups help individuals stay motivated and maintain long-term abstinence.
5. Increasing awareness and education: Awareness campaigns, educational programs, and public health initiatives aimed at highlighting the risks of nicotine addiction contribute to driving cessation efforts. By increasing awareness about the addictive nature of nicotine, the health consequences of tobacco use, and the benefits of quitting, individuals are motivated to seek nicotine de-addiction support.
6. Social and cultural factors: Changes in social norms and cultural attitudes toward smoking and tobacco use have also driven cessation efforts. As society becomes more conscious of the health risks and the negative societal impact of smoking, individuals are more likely to seek methods and support to quit nicotine addiction and give up tobacco use.
7. Accessibility of cessation programs and products: The availability and accessibility of cessation programs and nicotine replacement therapies influence individual decisions to seek help and attempt quitting. Increased availability, affordability, and ease of access to cessation resources, including counseling services, medications, and online support programs, contribute to the driving factors for nicotine de-addiction.
8. Peer influence and support: Peer support and encouragement from friends, family, and social networks play a significant role in driving cessation and de-addiction efforts. The support of others who have successfully quit or are going through the same process can provide motivation, guidance, and a sense of community during the quitting journey.
Overall, the driving factors for cessation and nicotine de-addiction include health concerns, government initiatives, NRT products, behavioral support, increasing awareness, changing social norms, accessibility of cessation programs and products, and peer influence. By addressing these factors and providing effective support, cessation and de-addiction efforts aim to reduce tobacco use, improve public health, and promote a tobacco-free society.
This report aims to provide a comprehensive presentation of the global market for Cessation and Nicotine De-Addiction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cessation and Nicotine De-Addiction.
Report Scope
The Cessation and Nicotine De-Addiction market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cessation and Nicotine De-Addiction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cessation and Nicotine De-Addiction companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kimree Technology Co.
GSK
Johnson & Johnson
Dr. Reddy’s Laboratories
Novartis AG
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Pfizer
Smoke Away
V2 Electronic Cigarettes
VaporFi
Mig Vapor
Halo Cigs
Segment by Type
Drug therapy
Nicotine Replacement Therapy (NRT)
Electronic cigarettes (E-cigarettes)
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cessation and Nicotine De-Addiction companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cessation and Nicotine De-Addiction Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug therapy
1.2.3 Nicotine Replacement Therapy (NRT)
1.2.4 Electronic cigarettes (E-cigarettes)
1.3 Market by Application
1.3.1 Global Cessation and Nicotine De-Addiction Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cessation and Nicotine De-Addiction Market Perspective (2019-2030)
2.2 Cessation and Nicotine De-Addiction Growth Trends by Region
2.2.1 Global Cessation and Nicotine De-Addiction Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cessation and Nicotine De-Addiction Historic Market Size by Region (2019-2024)
2.2.3 Cessation and Nicotine De-Addiction Forecasted Market Size by Region (2025-2030)
2.3 Cessation and Nicotine De-Addiction Market Dynamics
2.3.1 Cessation and Nicotine De-Addiction Industry Trends
2.3.2 Cessation and Nicotine De-Addiction Market Drivers
2.3.3 Cessation and Nicotine De-Addiction Market Challenges
2.3.4 Cessation and Nicotine De-Addiction Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cessation and Nicotine De-Addiction Players by Revenue
3.1.1 Global Top Cessation and Nicotine De-Addiction Players by Revenue (2019-2024)
3.1.2 Global Cessation and Nicotine De-Addiction Revenue Market Share by Players (2019-2024)
3.2 Global Cessation and Nicotine De-Addiction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cessation and Nicotine De-Addiction Revenue
3.4 Global Cessation and Nicotine De-Addiction Market Concentration Ratio
3.4.1 Global Cessation and Nicotine De-Addiction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cessation and Nicotine De-Addiction Revenue in 2023
3.5 Cessation and Nicotine De-Addiction Key Players Head office and Area Served
3.6 Key Players Cessation and Nicotine De-Addiction Product Solution and Service
3.7 Date of Enter into Cessation and Nicotine De-Addiction Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cessation and Nicotine De-Addiction Breakdown Data by Type
4.1 Global Cessation and Nicotine De-Addiction Historic Market Size by Type (2019-2024)
4.2 Global Cessation and Nicotine De-Addiction Forecasted Market Size by Type (2025-2030)
5 Cessation and Nicotine De-Addiction Breakdown Data by Application
5.1 Global Cessation and Nicotine De-Addiction Historic Market Size by Application (2019-2024)
5.2 Global Cessation and Nicotine De-Addiction Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cessation and Nicotine De-Addiction Market Size (2019-2030)
6.2 North America Cessation and Nicotine De-Addiction Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cessation and Nicotine De-Addiction Market Size by Country (2019-2024)
6.4 North America Cessation and Nicotine De-Addiction Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cessation and Nicotine De-Addiction Market Size (2019-2030)
7.2 Europe Cessation and Nicotine De-Addiction Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cessation and Nicotine De-Addiction Market Size by Country (2019-2024)
7.4 Europe Cessation and Nicotine De-Addiction Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cessation and Nicotine De-Addiction Market Size (2019-2030)
8.2 Asia-Pacific Cessation and Nicotine De-Addiction Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cessation and Nicotine De-Addiction Market Size by Region (2019-2024)
8.4 Asia-Pacific Cessation and Nicotine De-Addiction Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cessation and Nicotine De-Addiction Market Size (2019-2030)
9.2 Latin America Cessation and Nicotine De-Addiction Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cessation and Nicotine De-Addiction Market Size by Country (2019-2024)
9.4 Latin America Cessation and Nicotine De-Addiction Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cessation and Nicotine De-Addiction Market Size (2019-2030)
10.2 Middle East & Africa Cessation and Nicotine De-Addiction Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cessation and Nicotine De-Addiction Market Size by Country (2019-2024)
10.4 Middle East & Africa Cessation and Nicotine De-Addiction Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kimree Technology Co.
11.1.1 Kimree Technology Co. Company Detail
11.1.2 Kimree Technology Co. Business Overview
11.1.3 Kimree Technology Co. Cessation and Nicotine De-Addiction Introduction
11.1.4 Kimree Technology Co. Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.1.5 Kimree Technology Co. Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Cessation and Nicotine De-Addiction Introduction
11.2.4 GSK Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Cessation and Nicotine De-Addiction Introduction
11.3.4 Johnson & Johnson Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Dr. Reddy’s Laboratories
11.4.1 Dr. Reddy’s Laboratories Company Detail
11.4.2 Dr. Reddy’s Laboratories Business Overview
11.4.3 Dr. Reddy’s Laboratories Cessation and Nicotine De-Addiction Introduction
11.4.4 Dr. Reddy’s Laboratories Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.4.5 Dr. Reddy’s Laboratories Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Cessation and Nicotine De-Addiction Introduction
11.5.4 Novartis AG Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.5.5 Novartis AG Recent Development
11.6 The Harvard Drug Group
11.6.1 The Harvard Drug Group Company Detail
11.6.2 The Harvard Drug Group Business Overview
11.6.3 The Harvard Drug Group Cessation and Nicotine De-Addiction Introduction
11.6.4 The Harvard Drug Group Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.6.5 The Harvard Drug Group Recent Development
11.7 Perrigo Company
11.7.1 Perrigo Company Company Detail
11.7.2 Perrigo Company Business Overview
11.7.3 Perrigo Company Cessation and Nicotine De-Addiction Introduction
11.7.4 Perrigo Company Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.7.5 Perrigo Company Recent Development
11.8 Fontem Ventures
11.8.1 Fontem Ventures Company Detail
11.8.2 Fontem Ventures Business Overview
11.8.3 Fontem Ventures Cessation and Nicotine De-Addiction Introduction
11.8.4 Fontem Ventures Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.8.5 Fontem Ventures Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cessation and Nicotine De-Addiction Introduction
11.9.4 Pfizer Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Smoke Away
11.10.1 Smoke Away Company Detail
11.10.2 Smoke Away Business Overview
11.10.3 Smoke Away Cessation and Nicotine De-Addiction Introduction
11.10.4 Smoke Away Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.10.5 Smoke Away Recent Development
11.11 V2 Electronic Cigarettes
11.11.1 V2 Electronic Cigarettes Company Detail
11.11.2 V2 Electronic Cigarettes Business Overview
11.11.3 V2 Electronic Cigarettes Cessation and Nicotine De-Addiction Introduction
11.11.4 V2 Electronic Cigarettes Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.11.5 V2 Electronic Cigarettes Recent Development
11.12 VaporFi
11.12.1 VaporFi Company Detail
11.12.2 VaporFi Business Overview
11.12.3 VaporFi Cessation and Nicotine De-Addiction Introduction
11.12.4 VaporFi Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.12.5 VaporFi Recent Development
11.13 Mig Vapor
11.13.1 Mig Vapor Company Detail
11.13.2 Mig Vapor Business Overview
11.13.3 Mig Vapor Cessation and Nicotine De-Addiction Introduction
11.13.4 Mig Vapor Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.13.5 Mig Vapor Recent Development
11.14 Halo Cigs
11.14.1 Halo Cigs Company Detail
11.14.2 Halo Cigs Business Overview
11.14.3 Halo Cigs Cessation and Nicotine De-Addiction Introduction
11.14.4 Halo Cigs Revenue in Cessation and Nicotine De-Addiction Business (2019-2024)
11.14.5 Halo Cigs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
